APA

Patel P. B., Brett S. J., O'Callaghan D., Anjum A., Cross M., Warwick J. & Gordon A. C. (20210427). Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial. : Intensive care medicine.

Chicago

Patel Parind B, Brett Stephen J, O'Callaghan David, Anjum Aisha, Cross Mary, Warwick Jane and Gordon Anthony C. 20210427. Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial. : Intensive care medicine.

Harvard

Patel P. B., Brett S. J., O'Callaghan D., Anjum A., Cross M., Warwick J. and Gordon A. C. (20210427). Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial. : Intensive care medicine.

MLA

Patel Parind B, Brett Stephen J, O'Callaghan David, Anjum Aisha, Cross Mary, Warwick Jane and Gordon Anthony C. Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial. : Intensive care medicine. 20210427.